Newtyn Management, LLC Exact Sciences Corp Transaction History

Newtyn Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $9.48 Million - $26.1 Million	-250,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $7.77 Million - $9.97 Million	100,000 Added 66.67%	250,000 $23.1 Million
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $19.8 Million - $30.8 Million	-318,828 Reduced 68.01%	150,000 $13 Million
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $17.9 Million - $26.4 Million	318,828 Added 212.55%	468,828 $29.6 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $5.68 Million - $10.5 Million	150,000 New	150,000 $8.97 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Newtyn Management, LLC with notifications on news.